Skip to main content
Top
Published in: Annals of General Psychiatry 1/2010

Open Access 01-04-2010 | Meeting abstract

Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine

Authors: Julio Zarra, Luisa Schmidt

Published in: Annals of General Psychiatry | Special Issue 1/2010

Login to get access

Excerpt

The efficacy, safety, and tolerability of nootropic cholinergic agent: GALANTAMINE (with a dual mechanism of action on the cholinergic a system) and moderate affinity NMDA- receptor antagonist: MEMANTINE, were assessed taking into account the profile of patients with neurocognitive disorder: Alzheimer's disease, from the clinical aspects and the different classifications. …
Literature
1.
go back to reference Blesa R: Galantamine: therapeutics effects beyond cognition. Dement Geriatr Cogn Disord. 2000, 11 (suppl 1): 28-34. 10.1159/000051229.CrossRefPubMed Blesa R: Galantamine: therapeutics effects beyond cognition. Dement Geriatr Cogn Disord. 2000, 11 (suppl 1): 28-34. 10.1159/000051229.CrossRefPubMed
2.
go back to reference Sramek JJ, Veroff AE, et al: The status of ongoing trials for mild cognitive impairment. Expert Opin Inveting Drugs. 2001, 10 (4): 741-752. 10.1517/13543784.10.4.741.CrossRef Sramek JJ, Veroff AE, et al: The status of ongoing trials for mild cognitive impairment. Expert Opin Inveting Drugs. 2001, 10 (4): 741-752. 10.1517/13543784.10.4.741.CrossRef
Metadata
Title
Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
Authors
Julio Zarra
Luisa Schmidt
Publication date
01-04-2010
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue Special Issue 1/2010
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/1744-859X-9-S1-S118

Other articles of this Special Issue 1/2010

Annals of General Psychiatry 1/2010 Go to the issue